Aparajita Sarkar Selected Research

Neuroprotective Agents

4/2005

Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aparajita Sarkar Research Topics

Disease

3	Neoplasms (Cancer) 02/2004 - 06/2003
3	Prostatic Neoplasms (Prostate Cancer) 02/2004 - 06/2003
1	Type 2 Diabetes Mellitus (MODY) 11/2022
1	Metabolic Diseases (Metabolic Disease) 11/2022
1	Wounds and Injuries (Trauma) 01/2011
1	Huntington Disease (Huntington's Disease) 04/2005
1	Body Weight (Weight, Body) 10/2003

Drug/Important Bio-Agent (IBA)

4	PolyaminesIBA 02/2004 - 06/2003
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	PrebioticsIBA 11/2022
1	GlycosaminoglycansIBA 01/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011
1	ChemokinesIBA 01/2011
1	Phosphates (Orthophosphate)IBA 01/2011
1	CollagenIBA 01/2011
1	CystamineIBA 04/2005
1	TransglutaminasesIBA 04/2005
1	Neuroprotective AgentsIBA 04/2005
1	Antineoplastic Agents (Antineoplastics)IBA 02/2004
1	Adenosine Triphosphate (ATP)IBA 02/2004
1	tetramethylenedisulfotetramine (DSTA)IBA 10/2003
1	Methenamine (Hexamine)IBA 10/2003
1	Growth InhibitorsIBA 10/2003
1	cyclopropaneIBA 10/2003
1	eicosaneIBA 06/2003
1	3,8,13,18- tetraaza- 10,11- ((E)- 1,2- cyclopropyl)eicosane tetrahydrochlorideIBA 06/2003